Skip to content

Drug interactions

Netupitant-palonosetron + Siponimod

Severity: Moderate

Netupitant-palonosetron and Siponimod: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Siponimod is metabolized mainly by CYP2C9 with a smaller CYP3A4 contribution. Netupitant inhibits CYP3A4 moderately, which can raise siponimod exposure, especially in patients with reduced CYP2C9 activity. Higher siponimod levels increase the risk of bradycardia, infections and other adverse effects.

What this interaction means in plain words

Netupitant-palonosetron and Siponimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Netupitant-palonosetron belongs to Gastrointestinal Tract; Siponimod belongs to Central Nervous System.

Evidence level: Moderate

Why it happens

Netupitant inhibits CYP3A4, reducing a secondary clearance pathway of siponimod.

What to do

Check the patient's CYP2C9 genotype or any other CYP2C9 inhibitors; siponimod labeling advises against combining with dual moderate CYP3A4/CYP2C9 inhibition. For a single short antiemetic course, monitor heart rate and adverse effects, or choose an alternative antiemetic.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Netupitant-palonosetron and Siponimod, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Netupitant-palonosetron with Siponimod?

MediHelp rates the interaction as moderate. Netupitant-palonosetron and Siponimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Siponimod is metabolized mainly by CYP2C9 with a smaller CYP3A4 contribution. Netupitant inhibits CYP3A4 moderately, which can raise siponimod exposure, especially in patients with reduced CYP2C9 activity. Higher siponimod levels increase the risk of bradycardia, infections and other adverse effects.

How serious is the interaction between Netupitant-palonosetron and Siponimod?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Check the patient's CYP2C9 genotype or any other CYP2C9 inhibitors; siponimod labeling advises against combining with dual moderate CYP3A4/CYP2C9 inhibition. For a single short antiemetic course, monitor heart rate and adverse effects, or choose an alternative antiemetic.

What other medicines interact with Netupitant-palonosetron?

MediHelp also lists interactions of Netupitant-palonosetron with, for example, Apomorphine, Flibanserin, Apalutamide. The full list is on the Netupitant-palonosetron page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in